Folic acid inhibits homocysteine-induced superoxide anion production and nuclear factor kappa B activation in macrophages

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 1, 2006, Pages 141-147

  Au Yeung, Kathy K W ^a   Yip, Johnny C W ^a   Siow, Yaw L ^a   Karmin, O K ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Folic acid; Homocysteine; NADPH oxidase; NF B; Oxidative stress

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; HEART PROTECTION; HUMAN; HUMAN CELL; MACROPHAGE; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

CELL LINE; CHEMOKINE CCL2; FOLIC ACID; GENE EXPRESSION REGULATION; HOMOCYSTEINE; HUMANS; MACROPHAGES; NADPH OXIDASE; NF-KAPPA B; RNA, MESSENGER; SUPEROXIDES;

EID: 33745790096     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-136     Document Type: Conference Paper

References (38)

1. Au-Yeung, K.K., Woo, C.W., Sung, F.L., Yip, J.C., Siow, Y.L., and O, K. 2004. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ. Res. 94: 28-36. doi: 10.1161/01.RES.0000108264. 67601.2C. PMID: 14630727.
2. Babior, B.M. 1999. NADPH oxidase: an update. Blood, 93: 1464-1476. PMID: 10029572.
3. Bowie, A., and O'Neill, L.A. 2000. Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59: 13-23. doi: 10. 1016/S0006-2952(99) 00296-8. PMID: 10605930.
4. Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., et al. 1996. Activated transcription factor nuclear factor-κ B is present in the atherosclerotic lesion. J. Clin. Invest. 97: 1715-1722. PMID: 8601637.
5. Chambers, J.C., Ueland, P.M., Obeid, O.A., Wrigley, J., Refsum, H., and Kooner, J.S. 2000. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation, 102: 2479-2483. PMID: 11076820.
6. Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., and Graham, I. 1991. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324: 1149-1155. PMID: 2011158.
7. Dayal, S., Brown, K.L., Weydert, C.J., Oberley, L.W., Arning, E., Bottiglieri, T., Faraci, F.M., and Lentz, S.R. 2002. Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 22: 1996-2002. PMID: 12482825.
8. Doshi, S.N., McDowell, I.F., Moat, S.J., Payne, N., Durrant, H.J., Lewis, M.J., and Goodfellow, J. 2002. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation, 105: 22-26. doi: 10.1161/hc0102.101388. PMID: 11772871.
9. Duell, P.B., and Malinow, M.R. 1997. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr. Opin. Lipidol. 8: 28-34. PMID: 9127708.
10. Durand, P., Lussier-Cacan, S., and Blache, D. 1997. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J. 11: 1157-1168. PMID: 9367351.
11. Groemping, Y., Lapouge, K., Smerdon, S.J., and Rittinger, K. 2003. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell, 113: 343-355. doi: 10.1016/S0092-8674(03)00314-3. PMID: 12732142.
12. Harker, L.A., Slichter, S.J., Scott, C.R., and Ross, R. 1974. Homocystinemia: vascular injury and arterial thrombosis. N. Engl. J. Med. 291: 537-543. PMID: 4212055.
13. Kalinina, N., Agrotis, A., Tararak, E., Antropova, Y., Kanellakism, P., Ilyinskaya, O., et al. 2002. Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 22: 2037-2043. PMID: 12482831.
14. Kanani, P.M., Sinkey, C.A., Browning, R.L., Allaman, M., Knapp, H.R., and Haynes, W.G. 1999. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation, 100: 1161-1168. PMID: 10484535.
15. Karin, M., and Ben-Neriah, Y. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18: 621-663. doi: 10.1146/annurev.immunol.18.1.621. PMID: 10837071.
16. Malinow, M.R. 1990. Hyperhomocysteinemia: a common and easily reversible risk factor for occlusive atherosclerosis. Circulation, 81: 2004-2006. PMID: 2188759.
17. Nygard, O., Nordrehaug, J.E., Refsum, H., Ueland, P.M., Farstad, M., and Vollset, S.E. 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337: 230-236. doi: 10.1056/NEJM199707243370403. PMID: 9227928.
18. O, K., Lynn, E.G., Chung, Y.H., Siow, Y.L., Man, R.Y., and Choy, P.C. 1998. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim. Biophys. Acta, 1393: 317-324. PMID: 9748642.
19. Refsum, H., Ueland, P.M., Nygard, O., and Vollset, S.E. 1998. Homocysteine and cardiovascular disease. Annu. Rev. Med. 49: 31-62. PMID: 9509248.
20. Robinson, J.M., Ohira, T., and Badwey, J.A. 2004. Regulation of the NADPH-oxidase complex of phagocytic leukocytes. Recent insights from structural biology, molecular genetics, and microscopy. Histochem. Cell Biol. 122: 293-304. doi: 10.1007/s00418-004-0672-2. PMID: 15365846.
21. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362: 801-809. doi: 10.1038/362801a0. PMID: 8479518.
22. Simeonidis, S., Stauber, D., Chen, G., Hendrickson, W.A., and Thanos, D. 1999. Mechanisms by which IκB proteins control NF-κB activity. Proc. Natl. Acad. Sci. USA, 96: 49-54. doi: 10. 1073/pnas.96.1.49. PMID: 9874770.
23. Sorescu, D., Weiss, D., Lassegue, B., Clempus, R.E., Szocs, K., Sorescu, G.P., et al. 2002. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation, 105: 1429-1435. doi: 10.1161/01.CIR. 0000012917.74432.66. PMID: 11914250.
24. Suzukawa, M., Abbey, M., Clifton, P., and Nestel, P.J. 1994. Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages. Atherosclerosis, 110: 77-86. doi: 10.1016/0021-9150(94)90070-1. PMID: 7857373.
25. Thurberg, B.L., and Collins, T. 1998. The nuclear factor-κB/ inhibitor of κB autoregulatory system and atherosclerosis. Curr. Opin. Lipidol. 9: 387-396. PMID: 9812192.
26. Tsai, J.C., Perrella, M.A., Yoshizumi, M., Hsieh, C.M., Haber, E., Schlegel, R., and Lee, M.E. 1994. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. USA, 91: 6369-6373. PMID: 8022789.
27. Uerre, J.A., and Miller, C.H. 1966. Preparation of L-homocysteine from L-homocysteine thiolactone. Anal. Biochem. 17: 310-315. PMID: 5971425.
28. Van Heerebeek, L., Meischl, C., Stooker, W., Meijer, C.J., Niessen, H.W., and Roos, D. 2002. NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J. Clin. Pathol. 55: 561-568. doi: 10.1136/jcp.55.8.561. PMID: 12147646.
29. Wang, G., Siow, Y.L., and O, K. 2000. Homocysteine stimulates nuclear factor κBκB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem. J. 352: 817-826. doi: 10. 1042/0264-6021:3520817. PMID: 11104691.
30. Wang, G., Siow, Y.L., and O, K. 2001. Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-κB in THP-1 macrophages. Am. J. Physiol. Heart Circ. Physiol. 280: H2840-H2847. PMID: 11356643.
31. Wang, G., Woo, C.W., Sung, F.L., Siow, Y.L., and O, K. 2002. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 22: 1777-1783. PMID: 12426204.
32. Weiss, N., Heydrick, S., Zhang, Y.Y., Bierl, C., Cap, A., and Loscalzo, J. 2002. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler. Thromb. Vasc. Biol. 22: 34-41. PMID: 11788458.
33. Welch, G.N., and Loscalzo, J. 1998. Homocysteine and atherothrombosis. N. Engl. J. Med. 338: 1042-1050. doi: 10.1056/NEJM199804093381507. PMID: 9535670.
34. Wilmink, H.W., Stroes, E.S., Erkelens, W.D., Gerritsen, W.B., Wever, R., Banga, J.D., and Rabelink, T.J. 2000. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 20: 185-188. PMID: 10634816.
35. Woo, C.W., Cheung, F., Chan, V.W., Siow, Y.L., and O, K. 2003. Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide. Mol. Cell. Biochem. 243: 37-47. doi: 10.1023/A:1021601512058. PMID: 12619887.
36. Woo, K.S., Chook, P., and Lolin, Y.I. 1997. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation, 96: 2542-2544. PMID: 9355891.
37. Woo, K.S., Chook, P., Lolin, Y.I., Sanderson, I.E., Metreweli, C., and Celermajer, D.S. 1999. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J. Am. Coll. Cardiol. 34: 2002-2006. doi: 10.1016/S0735-1097(99)00469-6. PMID: 10588216.
38. Woo, C.W., Siow, Y.L., Pierce, G.N., Choy, P.C., Minuk, G.Y., Mymin, D., and O, K. 2005. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am. J. Physiol. Endocrinol. Metab. 288: E1002-E1010. PMID: 15644462.